329 results on '"Baroni Marco Giorgio"'
Search Results
2. Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus
3. Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk
4. MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus
5. Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus
6. Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment
7. Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes
8. Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes
9. A long-term nationwide study on chronic kidney disease-related mortality in Italy: trends and associated comorbidity
10. High pro-neurotensin levels in individuals with type 1 diabetes associate with the development of cardiovascular risk factors at follow-up
11. GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: New Insights and Opportunities for Cardiovascular Protection
12. Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk
13. Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control
14. Prevalence of Mildly Reduced Estimated GFR by Height- or Age-Related Equations in Young People With Obesity and Its Association with Cardiometabolic Risk Factors
15. Effects of work status changes and perceived stress on glycaemic control in individuals with type 1 diabetes during COVID-19 lockdown in Italy
16. Iodine Intake and Testosterone
17. Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity
18. Validation in type 2 diabetes of a metabolomic signature of all‐cause mortality
19. Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity
20. Effect of antioxidants on semen parameters in men with oligo‐astheno‐teratozoospermia: a network meta‐analysis.
21. Validation in type 2 diabetes of a metabolomic signature of all‐cause mortality.
22. Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?
23. Effect of antioxidants on semen parameters in men with oligo‐astheno‐teratozoospermia: a network meta‐analysis
24. GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: New Insights and Opportunities for Cardiovascular Protection
25. Impact of the 2017 Blood Pressure Guidelines by the American Academy of Pediatrics in overweight/obese youth
26. Reduced High-Density Lipoprotein Cholesterol Is an Independent Determinant of Altered Bone Quality in Women with Type 2 Diabetes
27. Neurotensin Gene rs2234762 C>G Variant Associates with Reduced Circulating Pro-NT Levels and Predicts Lower Insulin Resistance in Overweight/Obese Children
28. Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes
29. Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta‐analysis
30. Supplemental Materials for Dei Cas A (JCEM 2023) Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes
31. Genetic analysis of non-insulin dependent diabetes mellitus (NIDDM) using DNA markers at candidate gene loci
32. Impact of the 2017 Blood Pressure Guidelines by the American Academy of Pediatrics in overweight/obese youth
33. Testing for type 1 diabetes autoantibodies in gestational diabetes mellitus (GDM): is it clinically useful?
34. Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes.
35. Infection rate of penile prosthesis implants in men with spinal cord injury: a meta-analysis of available evidence
36. Uric acid versus metabolic syndrome as markers of fatty liver disease in young people with overweight/obesity
37. MODY: quando diagnosticarlo
38. Effects of Metformin and Exercise Training, Alone or in Combination, on Cardiac Function in Individuals with Insulin Resistance
39. PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals
40. New Insights in the Control of Fat Homeostasis: The Role of Neurotensin
41. Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans
42. Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study
43. The rs45454496 (E1813K) variant in the adiposity gene ANK2 doesn't associate with obesity in Southern European subjects
44. High pro-neurotensin levels in individuals with type 1 diabetes associate with the development of cardiovascular risk factors at follow-up
45. Erectile dysfunction in hyperuricemia: A prevalence meta‐analysis and meta‐regression study
46. A long-term nationwide study on chronic kidney disease-related mortality in Italy: trends and associated comorbidity
47. Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization
48. COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications
49. Independent association of atherogenic dyslipidaemia with all-cause mortality in individuals with type 2 diabetes and modifying effect of gender: A prospective cohort study
50. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤50 years)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.